 Bupropion
"Bupropion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment.
| Descriptor ID |
D016642
|
| MeSH Number(s) |
D02.522.818.110
|
| Concept/Terms |
Bupropion- Bupropion
- Amfebutamone
- (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
Zyntabac- Zyntabac
- Glaxo Wellcome Brand 3 of Bupropion Hydrochloride
Quomen- Quomen
- Esteve Brand of Bupropion Hydrochloride
Wellbutrin- Wellbutrin
- GlaxoSmithKline Brand 2 of Bupropion Hydrochloride
- Glaxo Wellcome Brand 2 of Bupropion Hydrochloride
Zyban (Anti-Smoking)- Zyban (Anti-Smoking)
- GlaxoSmithKline Brand 1 of Bupropion Hydrochloride
- Glaxo Wellcome Brand 1 of Bupropion Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Bupropion".
Below are MeSH descriptors whose meaning is more specific than "Bupropion".
This graph shows the total number of publications written about "Bupropion" by people in this website by year, and whether "Bupropion" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bupropion" by people in Profiles.
-
Pearce RE, Gaedigk R, Twist GP, Dai H, Riffel AK, Leeder JS, Gaedigk A. Developmental Expression of CYP2B6: A Comprehensive Analysis of mRNA Expression, Protein Content and Bupropion Hydroxylase Activity and the Impact of Genetic Variation. Drug Metab Dispos. 2016 07; 44(7):948-58.
-
Rytting E, Wang X, Vernikovskaya DI, Zhan Y, Bauer C, Abdel-Rahman SM, Ahmed MS, Nanovskaya TN. Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus). Drug Metab Dispos. 2014 Oct; 42(10):1773-9.
-
Choi WS, Faseru B, Beebe LA, Greiner AK, Yeh HW, Shireman TI, Talawyma M, Cully L, Kaur B, Daley CM. Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial. Trials. 2011 May 18; 12:126.
-
Catley D, Harris KJ, Okuyemi KS, Mayo MS, Pankey E, Ahluwalia JS. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine Tob Res. 2005 Dec; 7(6):859-70.
-
Richter KP, McCool RM, Catley D, Hall M, Ahluwalia JS. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. J Addict Dis. 2005; 24(4):79-90.
-
Boardman T, Catley D, Mayo MS, Ahluwalia JS. Self-efficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med. 2005; 12(4):266-72.
-
Harris KJ, Okuyemi KS, Catley D, Mayo MS, Ge B, Ahluwalia JS. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med. 2004 Apr; 38(4):498-502.
-
Okah FA, Okuyemi KS, McCarter KS, Harris KJ, Catley D, Kaur H, Ahluwalia JS. Predicting adoption of home smoking restriction by inner-city black smokers. Arch Pediatr Adolesc Med. 2003 Dec; 157(12):1202-5.
-
Okuyemi KS, Ahluwalia JS, Ebersole-Robinson M, Catley D, Mayo MS, Resnicow K. Does menthol attenuate the effect of bupropion among African American smokers? Addiction. 2003 Oct; 98(10):1387-93.
-
Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA. 2002 Jul 24-31; 288(4):468-74.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|